# Neumora Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Oct 29, 2025

- Company: [Neumora Therapeutics, Inc.](/companies/nmra.md) (CIK 1885522)
- Form: SCHEDULE 13D/A
- Filed: 2025-10-29
- Accepted by EDGAR: Oct 29, 2025, 19:07 ET
- Period: not reported
- Accession: 0001012975-25-000675
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1885522/000101297525000675/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1885522/000101297525000675/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1885522/000101297525000675/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Oct 29, 2025.
Source: SEC EDGAR, the filing index for accession 0001012975-25-000675. Last ingested by Listed: Oct 30, 2026, 16:11 ET. No prices; not investment advice.
